[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Sign in to use this feature.

Years

Between: -

Article Types

Countries / Regions

Search Results (2)

Search Parameters:
Journal = Reports
Section = Neurology

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
7 pages, 2975 KiB  
Case Report
Navigating Complexity in Pediatric NMOSD: Unusual Symptoms and Adverse Reactions: A Case Report
by Oana-Aurelia Vladâcenco, Radu-Ștefan Perjoc, Eugenia Roza and Raluca Ioana Teleanu
Reports 2025, 8(1), 6; https://doi.org/10.3390/reports8010006 - 8 Jan 2025
Viewed by 625
Abstract
Background and Clinical Significance: Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune demyelinating disorder of the central nervous system, characterized by the presence of aquaporin-4 (AQP4) antibodies and a high relapse rate. We provide information about the diagnosis, unusual symptoms, and [...] Read more.
Background and Clinical Significance: Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune demyelinating disorder of the central nervous system, characterized by the presence of aquaporin-4 (AQP4) antibodies and a high relapse rate. We provide information about the diagnosis, unusual symptoms, and treatment of a paediatric patient with NMOSD. Case Presentation: A 14-year-old girl was hospitalized for weakness and paraesthesia of the lower limbs (LL). The patient underwent detailed investigations and was diagnosed with NMOSD and cryptogenic organizing pneumonia. Initial treatment with methylprednisolone and prednisone yielded a favourable response. Therapy with mycophenolate was initiated. However, the patient experienced two more relapses, prompting the use of rituximab therapy with a favourable outcome and a two-year relapse-free follow-up period. Conclusions: Patients with NMOSD may have multisystemic inflammation, including organs outside the central nervous system. Our case report highlights a case of NMOSD, pulmonary involvement, and unusual adverse reactions to rituximab. Full article
(This article belongs to the Section Neurology)
Show Figures

Figure 1

Figure 1
<p>Spinal MRI showing cervical and thoracic (C6-T8) hyperintense lesions on T2-weighted imaging (White arrows).</p>
Full article ">Figure 2
<p>(<b>A</b>,<b>B</b>) CT scan of the chest showing ground opacities and patchy consolidation in the periphery of the right lower (white arrows) lobe before methylprednisolone.</p>
Full article ">Figure 3
<p>CT scan of the chest after treatment with methylprednisolone.</p>
Full article ">Figure 4
<p>CT scans of the chest during the first relapse, showing ground opacities (white arrows) in the right lower lobe.</p>
Full article ">
5 pages, 865 KiB  
Case Report
Intradural Melanotic Schwannoma of the Sacral Spine: An Illustrated Case Report of Diagnostic Conundrum
by Jiunn-Kai Chong, Navneet Kumar Dubey and Wen-Cheng Lo
Reports 2024, 7(3), 56; https://doi.org/10.3390/reports7030056 - 16 Jul 2024
Viewed by 1022
Abstract
Schwannomas are benign and slow-growing peripheral nerve sheath neoplasms of Schwann cells. These are generally encountered in the neck, head, and flexor areas of the extremities. Even though many schwannomas are easily diagnosable, their variable morphology can occasionally create difficulty in diagnosis. In [...] Read more.
Schwannomas are benign and slow-growing peripheral nerve sheath neoplasms of Schwann cells. These are generally encountered in the neck, head, and flexor areas of the extremities. Even though many schwannomas are easily diagnosable, their variable morphology can occasionally create difficulty in diagnosis. In this study, we present a rare case of melanotic schwannoma of the sacrum, emphasizing the need for routine biopsy to understand the etiology. A 46-year-old man presented to the Department of Neurosurgery, Taipei Medical University Hospital, with buttock pain in the sacrum area for 1 year, which worsened in the last 1–2 months. The patient had no known history of trauma or malignancy. We evidenced an intradural extramedullary neurogenic tumor at the caudal end from S1 to S3. Histologic analysis revealed melanin deposition in the tumor cells. Round to oval tumor cells were positive for HMB-45 and S-100 proteins, suggestive of melanotic Schwannoma, which were removed by laminectomy. After 1 month, the tumor recurred and was further removed surgically. Conclusively, we observed the sacrum as an unusual anatomic site for the possible occurrence of melanotic schwannoma, especially in patients with no known history of trauma and malignancy. The possibility of melanotic schwannoma is very high. We hypothesize that melanotic schwannoma was possible because it occurred in the intradural and extramedullary regions of the spine. Hence, a routine biopsy should be performed to corroborate the exact cause and prevent incorrect presumptions. Full article
(This article belongs to the Section Neurology)
Show Figures

Figure 1

Figure 1
<p>Intradural melanotic schwannoma. (<b>A</b>) Sagittal view showing sacral lesion at the S1–S3 with hyper-intensity on T1-weighted imaging (T1WI); heterogenous. (<b>A1</b>) The sagittal view revealed a sacral lesion with intense contrast enhancement (arrow), which was homogenous. (<b>B</b>) Sagittal view on T2WI axial MRI showing hypotense tumor infiltration into the spinal canal (<b>B1</b>). (<b>C</b>) Tumor with a bluish-black appearance during first surgery. (<b>D</b>) Hematoxylin and eosin stain, 200× magnification. Immunohistochemical stains reveal neoplastic cells positive for (<b>E</b>) HMB45, 400× magnification, and (<b>F</b>) S100, 400× magnification. (<b>G</b>,<b>H</b>) Follow-up MRI after the first surgery. (<b>I</b>) The sagittal view on T1WI showed tumor recurrence. (<b>J</b>) Follow-up MRI after the first surgery. The spinal canal was fully occupied by the tumor at the S1–S2 junction. (<b>K</b>) Tumor with a lesser bluish-black appearance than the first surgery. (<b>L</b>–<b>N</b>) Follow-up MRI after 2nd surgery showed no tumor within the spinal canal. (<b>O</b>) Post-operatively, spinal nerve within the thecal sac (blue arrow) can be seen clearly and pseu-do-meningocele (yellow arrow) was managed conservatively, which was confirmed by the absence of any symptoms.</p>
Full article ">
Back to TopTop